SCHEMBL7080443

SCHEMBL7080443

N#Cc1ccccc1Nc1ccc(C(=S)c2sccc2Cl)c(Cl)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 7/20 0.37
MAPK13 O15264 6/20 0.37
MAPK12 P53778 6/20 0.37
MAPK11 Q15759 6/20 0.37
ALDH1A1 P00352 5/20 0.37
GAA P10253 4/20 0.37
KDM4E B2RXH2 4/20 0.37
LMNA P02545 2/20 0.37
GLA P06280 1/20 0.37
LRRK2 Q5S007 1/20 0.36
HPGD P15428 2/20 0.36
MAPT P10636 2/20 0.36
KMT2A Q03164 1/20 0.35
IDO1 P14902 1/20 0.35
ALOX15 P16050 1/20 0.35
HSD17B10 Q99714 1/20 0.35
TAS2R14 Q9NYV8 1/20 0.35
CYP1A2 P05177 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
PDE7A Q13946 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7079266 0.87 MAPK13 (0.47) MAPK14MAPK13MAPK12MAPK11ALDH1A1
SCHEMBL7077185 0.86 MAPK13 (0.37) MAPK14MAPK13MAPK12MAPK11ALDH1A1
SCHEMBL7080246 0.85 MAPK14 (0.36) MAPK14MAPK13MAPK12MAPK11ALDH1A1
SCHEMBL7074987 0.83 MAPK14 (0.56) MAPK14MAPK13MAPK12MAPK11ALDH1A1
SCHEMBL7082053 0.83 MAPK14 (0.55) MAPK14MAPK13MAPK12MAPK11ALDH1A1
SCHEMBL7080447 0.82 SCN1A (0.39) ALDH1A1GAAHPGDMAPTKMT2A
SCHEMBL7076675 0.81 MAPK13 (0.47) MAPK14MAPK13MAPK12MAPK11ALDH1A1
SCHEMBL7079402 0.80 ALDH1A1 (0.41) MAPK14MAPK13MAPK12MAPK11ALDH1A1
SCHEMBL1903014 0.80 MAPK14 (0.55) MAPK14MAPK13MAPK12MAPK11ALDH1A1
SCHEMBL7078942 0.78 MAPK13 (0.57) MAPK14MAPK13MAPK12MAPK11ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030073832-A1 Novel aminophenyl ketone derivatives LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2003-04-17 US claimed
US-20030073832-A1 Novel aminophenyl ketone derivatives LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2003-04-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030073832-A1 Novel aminophenyl ketone derivatives MAPKAPK2, MAP3K2, MAP3K1 MAPK14 28/4885MAPK13 33/4885MAPK12 36/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.